Molecular pathology of neuronal differentiation, migration and death in developmental disorders.
发育障碍中神经元分化、迁移和死亡的分子病理学。
基本信息
- 批准号:08670933
- 负责人:
- 金额:$ 1.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A.Neuronal deathWe produced a polyclonal antibody against Bak, a protein promoting neuronal apoptosis, and thereby studied its expression in human brains by Western blotting and immunostaining. In 1996, we investigated the changes associated with development and aging, and demonstrated that the expression of Bak is high in the fetal and aged brains. In 1997, we comapared Bak immunoreactivity between Down syndrome and control patients. In Down syndrome brains, the aging-related upregulation of Bak occurred prematurely. Cerebral neurons became Bak-positive prior to the development of neurofibrillary changes.B.Neuronal differentiationWe produced rabbit antibodies against the N-and C-terminal of tuberin, the product of the TSC2 gene responsible for tuberous sclerosis. In 1996, we demonstrated the expression of tuberin in control cerebra. During development, tuberin content increased with age. Tuberous sclerosis brains by contrast showed loss of tuberin, which was severe in both the hamartomatous lesions (cortical tuber and subependymal giant cell tumor) and histologically normal cortices. Tuberin immunoreactivity was also lost from the renal and cardiac hamartomas. In 1997, we observed a normal level of tuberin expression in focal cortical dysplasia, thereby indicating pathophysiological difference between tuberous sclerosis and cortical dysplasia.C.Neuronal migrationWe extended immunohistochemical studies of the LIS1 gene product (a 45k subunit of PAF acetylhydrolase), the defect of which being responsible for the Miller-Dieker lissencephaly syndrome. In 1996, we studied the expression of LIS1 in various migration disorders, and demonstrated that the loss of LIS1 is specific to the syndrome. In 1997, we immunostained human fetal brains and observed strong labeling of the ventricular neuroepithlium and Cajal-Retzius cells.
A.神经元死亡我们制备了针对巴克(一种促进神经元凋亡的蛋白质)的多克隆抗体,从而通过蛋白质印迹和免疫染色研究了其在人脑中的表达。1996年,我们研究了与发育和衰老相关的变化,并证明巴克在胎儿和老年脑中的高表达。1997年,我们比较了唐氏综合征患者和对照组患者的巴克免疫反应性。在唐氏综合症患者的大脑中,与年龄相关的巴克蛋白上调过早发生。B.神经元分化我们制备了兔抗tuberin N-和C-末端的抗体,tuberin是负责结节性硬化症的TSC 2基因的产物。1996年,我们证明了tuberin在正常大脑中的表达。在发育过程中,块茎素含量随着年龄的增长而增加。相比之下,硬化性脑组织显示结节素的丢失,这在错构瘤病变(皮质结节和室管膜下巨细胞瘤)和组织学正常的皮质中都是严重的。肾和心脏错构瘤中也失去了免疫反应性。在1997年,我们观察到一个正常水平的tuberin表达局灶性皮质发育不良,从而表明结节性硬化症和皮质dysplasia.C之间的病理生理差异。神经元migrationWe延长免疫组化研究的LIS 1基因产物(PAF乙酰水解酶的45 k亚基),该缺陷是负责米勒-迪克无脑综合征。1996年,我们研究了LIS 1在各种迁移障碍中的表达,并证明LIS 1的缺失是该综合征特有的。在1997年,我们免疫染色人胎脑,并观察到心室神经上皮细胞和Cajal-Retzius细胞的强烈标记。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsuru A, et al.: "Abnormal expression of cell adhesion molecule L1 in migration disorder:A developmentalimmunohistochemical study" Clinical Neuropathology. 16(3). 122-126 (1997)
Tsuru A 等人:“迁移障碍中细胞粘附分子 L1 的异常表达:发育免疫组织化学研究”临床神经病理学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwama H,et al.: "Depletion of cerebral D-serine in non-ketotic hyperglycinemia : Possible involvement of glycine in control of endogenous D-serine." Biochem Biophys Res Commun. 231(3). 793-796 (1997)
Iwama H 等人:“非酮症高甘氨酸血症中大脑 D-丝氨酸的消耗:可能涉及甘氨酸控制内源性 D-丝氨酸。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwama H, et al.: "Depletion of cerebral D-serine in non-ketotic hyperglycinemia:Possible involvement of alvcine in control of endogenous D-serine." Biochemical and Biophysical Research Communications. 231(3). 793-796 (1997)
Iwama H 等人:“非酮症高甘氨酸血症中大脑 D-丝氨酸的消耗:可能涉及小肠氨酸控制内源性 D-丝氨酸。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizuguchi M.: "Development of Synaptic Transmission in Mental Retardation." National Center of Neurology and Psychiatry, 9 (1997)
Mizuguchi M.:“精神发育迟滞中突触传递的发展”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizuguchi M.: "Developmental expression of lissencephaly and tuberous sclerosis gene products." National Center of Neurology and Psychiatry (ed) Development of Synaptic Transmission in Mental Retardation.55-63 (1997)
Mizuguchi M.:“无脑畸形和结节性硬化症基因产物的发育表达。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIZUGUCHI Masashi其他文献
MIZUGUCHI Masashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIZUGUCHI Masashi', 18)}}的其他基金
Interface of neural activity, immunity and metabolism in acute encephalopathy
急性脑病的神经活动、免疫和代谢的界面
- 批准号:
15H04872 - 财政年份:2015
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prevention of autism by drug therapy targeting mTOR system in developing brain
通过针对发育中大脑 mTOR 系统的药物治疗预防自闭症
- 批准号:
26670491 - 财政年份:2014
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Crosstalk between serotonin and mTOR systems: molecular pathology in autism and its treatment
血清素和 mTOR 系统之间的串扰:自闭症的分子病理学及其治疗
- 批准号:
24659490 - 财政年份:2012
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Comprehensive gene analysis of acute encephalopathy to elucidate its variability and commonality
急性脑病的综合基因分析以阐明其变异性和共性
- 批准号:
24390258 - 财政年份:2012
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Behavioral pharmacological study to develop animal model systems for creating drugs to treat autism
行为药理学研究开发动物模型系统来制造治疗自闭症的药物
- 批准号:
22659190 - 财政年份:2010
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Etiology, pathology and pathogenesis of acute necrotizing encephalopathy and acute encephalopathy with biphasic seizures and late reduced diffusion
急性坏死性脑病和双相性癫痫发作及迟发弥散性急性脑病的病因、病理和发病机制
- 批准号:
20390293 - 财政年份:2008
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Experimental pathologic study on the pathogenesis of cerebral lesions in tuberous sclerosis
结节性硬化症脑病变发病机制的实验病理研究
- 批准号:
17500222 - 财政年份:2005
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathogenesis and epileptogenicity in tuberous sclerosis and focal cortical dysplasia
结节性硬化症和局灶性皮质发育不良的发病机制和致癫痫性
- 批准号:
13670831 - 财政年份:2001
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neuronal migration : its mechanism in normal development and pathologic changes in cerebral dysgenesis.
神经元迁移:其正常发育和脑发育不全病理变化的机制。
- 批准号:
10670753 - 财政年份:1998
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Distribution and function of phosphoinositide second messenger system in developing brain
磷酸肌醇第二信使系统在大脑发育中的分布和功能
- 批准号:
05670659 - 财政年份:1993
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Engineering a novel mitochondrial-targeting drug for epilepsy in tuberous sclerosis complex
设计一种新型线粒体靶向药物治疗结节性硬化症癫痫
- 批准号:
2887960 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Studentship
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex
免疫抑制在结节性硬化症肾病发生和进展中的机制
- 批准号:
10658079 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Novel Combination Therapy for Treatment and Prevention of PulmonaryLymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)
治疗和预防肺淋巴管平滑肌瘤病 (LAM) 和结节性硬化症 (TSC) 的新型联合疗法
- 批准号:
10697901 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Elucidation of Tumor Resistance Mechanisms in Tuberous Sclerosis Complex-Associated Renal Angiomyolipoma for the Design of Novel Nanotherapies
阐明结节性硬化症相关肾血管平滑肌脂肪瘤的肿瘤抵抗机制,用于设计新型纳米疗法
- 批准号:
10585048 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Disrupted ciliary signaling in the brain pathology of Tuberous Sclerosis Complex (Diversity Supplement)
结节性硬化症脑部病理学中纤毛信号传导中断(多样性补充剂)
- 批准号:
10516328 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Early Communication in Tuberous Sclerosis Complex (TSC) and its Prediction of Autism
结节性硬化症 (TSC) 的早期沟通及其对自闭症的预测
- 批准号:
10525384 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Early Communication in Tuberous Sclerosis Complex (TSC) and its Prediction of Autism
结节性硬化症 (TSC) 的早期沟通及其对自闭症的预测
- 批准号:
10672967 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Generation of model animals with autistic features of tuberous sclerosis complex and screening of therapeutics and biomarkers
具有结节性硬化症自闭症特征的模型动物的产生以及治疗方法和生物标志物的筛选
- 批准号:
22K07949 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neuroinflammation as a biomarker for epilepsy and neuropsychiatric comorbidities among people with tuberous sclerosis complex: a prospective, multicentre study
神经炎症作为结节性硬化症患者癫痫和神经精神合并症的生物标志物:一项前瞻性、多中心研究
- 批准号:
469794 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Operating Grants
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex
结节性硬化症肿瘤负荷中基因修饰的特征
- 批准号:
10359184 - 财政年份:2021
- 资助金额:
$ 1.6万 - 项目类别:














{{item.name}}会员




